Despite the absence of atorvastatin effects on APOE mRNA expression, those individuals without LDL cholesterol goal achievement according to the IV Brazilian Guidelines for Dyslipidemia and Atherosclerosis Prevention [8] had lower expression (p = 0.009; Figure 1B) than patients with desirable response after the treatment. This evidence concerns the gene APOE and atherosclerosis.